Category: Penny Stock NewsSort
The Guitammer Company, Inc. (GTMM) Becomes Member of D-Tools Manufacturer Vantage Point Program
D-Tools, the worldwide leader in system integration software, today announced that The Guitammer Company has joined its Manufacturer Vantage Point (MVP) program. Well known for the immersive entertainment experience provided by its award-winning line of ButtKicker®-brand low frequency audio transducers, The Guitammer Company is a leader in low frequency sound products and technology.
International Stem Cell Corporation (ISCO) Video Chart for Friday, March 22, 2013
ISCO is back on the climb this week, rising off a support level at the 200-day moving average and a Fibonacci retracement point. The pps is right near a resistance at 33 cents, but if that resistance falls, there is no resistance in the way until recent highs of 41 cents.
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
Viscount Systems, Inc. (VSYS) Announces Release Date of 2012 Financial Results, Investor Update Call to Follow
Viscount Systems, a leading-edge supplier of security systems and software, announced today that the company will be filing its financial results for the year ended December 31, 2012, with the SEC on Wednesday of next week.
The company also told investors that it will be hosting a conference call at 4:15pm EDT on the same day to discuss the financial results and provide a corporate update. Shareholders and all interested members of the financial community, including analysts, brokers and interested investors, are all invited to participate.
VentriPoint Diagnostics Ltd. (VPTDF) Pursues European and Canadian Approvals for New Non-Specific Heart Disease Application
Today before the opening bell, VentriPoint Diagnostics announced it has filed for CE Mark and Health Canada approvals for its database for non-specific heart disease (NRV). By using this database, clinicians can rapidly and accurately assess the status of the right ventricle (RV) in all patients that do not have significant congenital heart defects or Pulmonary Arterial Hypertension (PAH), yet may have a variety of other conditions, such as left-heart failure or valve disease.
International Stem Cell Corp. (ISCO) Schedules Conference Call to Discuss Positive Study Data of Parkinson’s Disease
International Stem Cell Corp., a California-based biotechnology company focused on therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that it will be hosting a conference call tomorrow morning to discuss results of its Parkinson’s Disease study that it presented at the American Academy of Neurology 65th Annual Meeting (AAN) this week. Dr. Ruslan Semechkin, Vice President of Research and Development for ISCO and Dr. Simon Craw, Executive Vice President, will host the call.
Cardium Therapeutics, Inc. (CXM) Builds a Diverse Approach to the Medical and Health Marketplace
Soul and Vibe Interactive, Inc. (SOUL) to Build Business at Game Connection Conference
Game Connection 2013 is being held in San Francisco, March 25th through the 27th, and is expected to draw roughly 1,000 key players from around the world representing the games industry, including game companies, publishers, distributors, investors, and IP owners. The conference is a major opportunity for deal making, with the average deal value at the conferences reportedly in the $400,000 range. It’s also notable that 90% of attendees expect direct business to result from the conference.
International Stem Cell Corp. (ISCO) Reports Positive Results of Primate Parkinson’s Study
International Stem Cell Corp., a biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSC), this morning announced the safety and encouraging efficacy of its stem cell therapy in rodent and non-human primate models of Parkinson’s disease.
“This pilot study represents a first essential step in bringing cell-based therapies for Parkinson’s disease to clinical trials,” stated co-author of the study Evan Y. Snyder, MD, PhD, Director of Stem Cells and Regenerative Biology Program at Sanford Burnham Medical Research Institute.
Soul and Vibe Interactive, Inc. (SOUL) Reports Plan to Monetize Avatars for Marketing Impressions and Additional Revenues
Soul and Vibe Interactive, a publisher of games for consoles, mobile devices, and personal computers, today told investors that its business model includes selling monetized games-related content, including virtual apparel, costume, and prop collections for Avatars. In addition to generating an additional stream of revenue, Avatar items can promote brand awareness for Soul and Vibe’s games and intellectual properties.
Loans4Less.com, Inc. (LFLS) Launches New Marketing Initiative to Reach a Potential 1.7 Million
Loans4Less.com, an online mortgage loan brokerage firm focused on conforming loans, today announced the company is ramping up its brand exposure and market penetration by launching a targeted newspaper advertising campaign to a circulation of more than 1.7 million readers in California.